IDYA
IDEAYA BiosciencesANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
IDYA vs peer average
82/100
IDYA vs. peer average (A vs. C)
Grade spread
B 3 · C 4 · D 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ELVN is the first available peer comparator.
Closest packet-listed operating comp as a clinical-stage oncology biotech, though indication overlap is limited; useful for sentiment on single-asset and data-driven valuation risk.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IDYA
IDEAYA Biosciences
ELVN
Enliven Therapeutics
Grade
A
D
Momentum
88
93
Value
41
41
Sentiment
66
20
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs ELVN
IDYA / ELVN
Grade Position
Above peers
IDYA vs. peer average (A vs. C)
82/100
Momentum
88
ELVNValue
41
IDYASentiment
66
IDYARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IDYA
ELVN is the first peer returned for this comparison set.